Fmoc-(S)-3-Amino-3-(2-fluorophenyl)propionic Acid: A Key Building Block for Peptide Synthesis and Drug Discovery

Unlock new possibilities in pharmaceutical research with Fmoc-(S)-3-Amino-3-(2-fluorophenyl)propionic acid. This specialized amino acid derivative is essential for creating advanced peptides and therapeutic compounds. Discover its applications and how to source it from a reliable manufacturer.

Get a Quote & Sample

Key Advantages of Our Fmoc-(S)-3-Amino-3-(2-fluorophenyl)propionic Acid

Exceptional Purity for Research Integrity

Our commitment to quality ensures that researchers and formulation scientists receive Fmoc-(S)-3-Amino-3-(2-fluorophenyl)propionic acid with exceptional purity, minimizing impurities that could affect experimental outcomes or final product efficacy.

Fluorine Substitution for Optimized Properties

The incorporation of fluorine atoms can significantly alter a molecule's lipophilicity, metabolic stability, and binding affinity. This specific amino acid derivative allows for the targeted introduction of these beneficial properties into peptides and drug candidates.

Facilitating Complex Molecular Design

As a sophisticated building block, it empowers scientists in medicinal chemistry to construct intricate peptide sequences and novel molecular architectures, essential for developing next-generation therapeutics.

Diverse Applications in Chemical Research and Development

Peptide Synthesis

A fundamental component in solid-phase peptide synthesis (SPPS) for creating custom peptide sequences with specific functionalities.

Drug Development

Crucial for synthesizing novel therapeutic agents where fluorine incorporation enhances pharmacological properties, such as increased efficacy or improved metabolic stability.

Medicinal Chemistry

A versatile intermediate for designing and synthesizing small molecules and peptidomimetics with targeted biological activities.

Biochemistry Research

Used in studies investigating structure-activity relationships of biologically relevant molecules and developing new diagnostic tools.